Anticoagulants can be prescribed to patients with chronic pancreatitis, but with caution due to the increased risk of gastrointestinal bleeding. Monitoring and dose adjustments are critical.

Patients with chronic pancreatitis can use anticoagulants, but must be closely monitored for signs of bleeding, particularly in the gastrointestinal tract, and require regular blood tests to manage dosing.

Use of anticoagulants in chronic pancreatitis patients is feasible but risky. Physicians should assess bleeding risks, especially gastrointestinal, and adjust anticoagulant dosage accordingly.